Chad Beynon

Stock Analyst at Macquarie

(3.02)
# 1,230
Out of 4,412 analysts
34
Total ratings
46.15%
Success rate
0.91%
Average return

21 Stocks

Hilton Worldwide Holdings
Apr 25, 2024
Maintains: Neutral
Price Target: $192$205
Current: $202.12
Upside: +1.42%
Monarch Casino & Resort
Apr 18, 2024
Maintains: Neutral
Price Target: $75$76
Current: $68.07
Upside: +11.65%
Century Casinos
Apr 10, 2024
Upgrades: Outperform
Price Target: n/a
Current: $3.00
Upside: -
Rush Street Interactive
Mar 7, 2024
Maintains: Outperform
Price Target: $6$8
Current: $6.06
Upside: +32.01%
Light & Wonder
Feb 28, 2024
Maintains: Outperform
Price Target: $100$115
Current: $91.31
Upside: +25.94%
PENN Entertainment
Feb 16, 2024
Maintains: Outperform
Price Target: $35$33
Current: $16.86
Upside: +95.73%
MGM Resorts International
Feb 14, 2024
Reiterates: Outperform
Price Target: $58
Current: $41.09
Upside: +41.15%
Wynn Resorts
Feb 9, 2024
Maintains: Outperform
Price Target: $122$128
Current: $95.88
Upside: +33.50%
Inspired Entertainment
Jan 17, 2024
Downgrades: Neutral
Price Target: $16$10
Current: $8.81
Upside: +13.51%
Full House Resorts
Jan 17, 2024
Downgrades: Neutral
Price Target: $8$6
Current: $5.38
Upside: +11.52%
Red Rock Resorts
Jan 17, 2024
Upgrades: Outperform
Price Target: $51$58
Current: $54.12
Upside: +7.17%
Gambling.com Group
Jun 28, 2023
Initiates: Outperform
Price Target: $13
Current: $8.73
Upside: +48.91%
Cinemark Holdings
May 8, 2023
Maintains: Outperform
Price Target: $18$20
Current: $17.65
Upside: +13.31%
Accel Entertainment
Nov 9, 2022
Maintains: Outperform
Price Target: $14$13
Current: $11.19
Upside: +16.18%
Golden Entertainment
Feb 18, 2022
Maintains: Outperform
Price Target: $64$66
Current: $32.41
Upside: +103.64%
Hyatt Hotels
Jan 18, 2022
Upgrades: Outperform
Price Target: $110
Current: $151.32
Upside: -27.31%
Reading International
Sep 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.65
Upside: -
AMC Entertainment Holdings
Sep 1, 2021
Downgrades: Underperform
Price Target: n/a
Current: $3.41
Upside: -
DraftKings
Mar 10, 2021
Maintains: Outperform
Price Target: n/a
Current: $43.13
Upside: -
Regencell Bioscience Holdings
Dec 6, 2017
Downgrades: Neutral
Price Target: n/a
Current: $5.08
Upside: -
Caesars Entertainment
Apr 20, 2017
Upgrades: Outperform
Price Target: n/a
Current: $36.61
Upside: -